Document Detail

Influence of recombinant interferon alpha on nutritional status and growth pattern in children with chronic viral hepatitis.
MedLine Citation:
PMID:  8956939     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: Significant but transient abnormalities of the nutritional status are encountered constantly at the beginning of rIFN-alpha therapy without any deleterious effect on growth. Information of the families and nutritional intervention during treatment should be required, in order to limit the importance of weight loss.
F Gottrand; L Michaud; D Guimber; S Ategbo; G Dubar; D Turck; J P Farriaux
Related Documents :
11759109 - Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and re...
24843339 - Pain relief after arthroscopic knee surgery: a comparison of intra-articular ropivacain...
11236109 - Switch of protease inhibitor-containing haart in routine clinical practice: a four-year...
24127679 - A randomised single-blind comparison of the effectiveness of tristel fuse (chlorine dio...
15310939 - Initiation of antiretroviral therapy: implications of recent findings.
15911439 - Spontaneous recovery of hemoglobin and neutrophil levels in japanese patients on a long...
24212479 - Long-term result of vocal cord paralysis after anterior cervical disectomy.
22286629 - Analysis of lung function test in patients with pleural empyema treated with thoracotom...
10693549 - Pseudarthrosis repair. autogenous iliac crest versus femoral ring allograft.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of pediatrics     Volume:  155     ISSN:  0340-6199     ISO Abbreviation:  Eur. J. Pediatr.     Publication Date:  1996 Dec 
Date Detail:
Created Date:  1997-03-25     Completed Date:  1997-03-25     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  1031-4     Citation Subset:  IM    
Service de Pédiatrie, Hôpital Huriez, CHRU de Lille, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antiviral Agents / adverse effects,  therapeutic use*
Child, Preschool
Chronic Disease
Growth / drug effects
Hepatitis B / drug therapy*
Hepatitis C / drug therapy*
Interferon Type I / adverse effects,  therapeutic use*
Nutritional Status / drug effects*
Recombinant Proteins
Weight Loss
Reg. No./Substance:
0/Antiviral Agents; 0/Interferon Type I; 0/Recombinant Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The use of acoustic reflectometry in the study of middle ear effusion in children suffering from acu...
Next Document:  Isolated dihydroxyacetonephosphate-acyl-transferase deficiency in rhizomelic chondrodysplasia puncta...